Filing Flows › Kestra Medical Technologies (KMTS) › Stock forecast & fair value
Kestra Medical Technologies (KMTS) stock forecast and price target
Kestra Medical Technologies (KMTS) trades at $28.80. 8 analysts' median price target is $30.00 (+4%), from $28.00 to $34.00.
Kestra Medical Technologies' latest quarter
Kestra Medical Technologies, Q1 FY27: revenue $31.0M (+60% year over year), operating margin -121.6%, net loss $44.1M, operating cash flow −$32.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for KMTS stock?
The median of 8 analysts' 12-month targets is $30.00, +4% from $28.80; the range is $28.00 to $34.00. The average rating is none.
Does Kestra Medical Technologies usually beat earnings estimates?
It beat the consensus EPS estimate in 100% of the quarters on record.
Is KMTS stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.